Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 06-Feb-24 6:01 PM View:  | Gilead Sciences Inc. (GILD) | 02-Feb-24 | Grant | 512 | -- | -- | 100% 0 to 0.51K | |
| 15-Dec-23 6:39 PM View: | Seattle Genetics Inc. (SGEN) | 14-Dec-23 | Disposition | 4,255 | $229.00 | $974,395.00 | (100%) 4.25K to 0 | |
| 26-Jun-23 4:11 PM View: | Royalty Pharma Plc (RPRX) | 23-Jun-23 | Grant | 7,747 | -- | -- | 27% 29.19K to 36.94K | |
| 02-Jun-23 6:22 PM View: | Seattle Genetics Inc. (SGEN) | 31-May-23 | Grant | 2,044 | -- | -- | 43% 4.7K to 6.75K | |
| 06-Oct-22 4:15 PM View: | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 576,318 | -- | -- | (62%) 922.62K to 346.3K | |
| 06-Oct-22 4:15 PM View: | Global Blood Therapeutics, ... (GBT) | 05-Oct-22 | Disposition | 346,300 | -- | -- | (100%) 346.3K to 0 | |
| 29-Sep-22 8:45 PM View: | Global Blood Therapeutics, ... (GBT) | 27-Sep-22 | Option Exercise | 18,291 | $16.40 | $299,972.00 | 2% 901.83K to 920.12K | |
| 29-Sep-22 8:45 PM View: | Global Blood Therapeutics, ... (GBT) | 13-Sep-22 | Gift | 35,300 | -- | -- | 4% 901.83K to 937.13K | |
| 29-Sep-22 8:45 PM View: | Global Blood Therapeutics, ... (GBT) | 13-Sep-22 | Gift | 35,300 | -- | -- | (4%) 937.13K to 901.83K | |
| 29-Sep-22 8:45 PM View: | Global Blood Therapeutics, ... (GBT) | 09-Sep-22 | Gift | 221,200 | -- | -- | (20%) 1.12M to 901.83K | |
| 06-Sep-22 7:00 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Payment of Exercise | 9,200 | $68.15 | $626,980.00 | (< 1%) 1.13M to 1.12M | |
| 06-Sep-22 7:00 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Sep-22 | Option Exercise | 18,553 | -- | -- | 2% 1.11M to 1.13M | |
| 03-Aug-22 6:01 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Aug-22 | Payment of Exercise | 10,018 | $32.40 | $324,583.00 | (< 1%) 1.12M to 1.11M | |
| 03-Aug-22 6:01 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Aug-22 | Option Exercise | 20,205 | -- | -- | 2% 1.1M to 1.12M | |
| 24-Jun-22 4:57 PM View: | Royalty Pharma Plc (RPRX) | 24-Jun-22 | Grant | 6,328 | -- | -- | 28% 22.87K to 29.19K | |
| 17-May-22 7:32 PM View: | Seattle Genetics Inc. (SGEN) | 13-May-22 | Grant | 1,503 | -- | -- | 47% 3.2K to 4.7K | |
| 03-Mar-22 8:51 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Mar-22 | Payment of Exercise | 4,074 | $29.87 | $121,690.00 | (< 1%) 1.11M to 1.1M | |
| 03-Mar-22 8:51 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Mar-22 | Option Exercise | 9,445 | -- | -- | < 1% 1.1M to 1.11M | |
| 03-Mar-22 8:51 PM View: | Global Blood Therapeutics, ... (GBT) | 28-Feb-22 | Grant | 839 | $25.37 | $21,285.40 | < 1% 1.1M to 1.1M | |
| 03-Feb-22 5:47 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Feb-22 | Payment of Exercise | 10,531 | $29.33 | $308,874.00 | (< 1%) 1.11M to 1.1M | |
| 03-Feb-22 5:47 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Feb-22 | Option Exercise | 29,955 | -- | -- | 3% 1.08M to 1.11M | |
| 03-Sep-21 8:00 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Sep-21 | Payment of Exercise | 4,683 | $29.85 | $139,788.00 | (< 1%) 1.11M to 1.1M | |
| 03-Sep-21 8:00 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Sep-21 | Option Exercise | 9,444 | -- | -- | < 1% 1.1M to 1.11M | |
| 03-Aug-21 7:07 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Aug-21 | Payment of Exercise | 14,853 | $27.33 | $405,932.00 | (1%) 1.11M to 1.1M | |
| 03-Aug-21 7:07 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Aug-21 | Option Exercise | 29,955 | -- | -- | 3% 1.08M to 1.11M | |
| 29-Jun-21 8:43 PM View: | Royalty Pharma Plc (RPRX) | 25-Jun-21 | Grant | 5,726 | -- | -- | 33% 17.14K to 22.87K | |
| 18-May-21 7:28 PM View: | Seattle Genetics Inc. (SGEN) | 14-May-21 | Grant | 1,402 | -- | -- | 78% 1.8K to 3.2K | |
| 03-Mar-21 7:38 PM View: | Global Blood Therapeutics, ... (GBT) | 28-Feb-21 | Grant | 370 | $36.21 | $13,397.70 | < 1% 1.08M to 1.08M | |
| 03-Feb-21 7:41 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Feb-21 | Payment of Exercise | 17,893 | $49.49 | $885,525.00 | (2%) 1.1M to 1.08M | |
| 03-Feb-21 7:41 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Feb-21 | Option Exercise | 42,018 | -- | -- | 4% 1.06M to 1.1M | |
| 18-Aug-20 7:53 PM View: | Seattle Genetics Inc. (SGEN) | 17-Aug-20 | Grant | 1,799 | -- | -- | 100% 0 to 1.8K | |
| 17-Aug-20 8:40 PM View: | Royalty Pharma Plc (RPRX) | 13-Aug-20 | Grant | 7,280 | -- | -- | 73% 10.0K to 17.28K | |
| 04-Aug-20 9:30 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Aug-20 | Payment of Exercise | 20,834 | $67.48 | $1,405,880.00 | (2%) 1.08M to 1.06M | 33% |
| 04-Aug-20 9:30 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Aug-20 | Option Exercise | 42,017 | -- | -- | 4% 1.04M to 1.08M | |
| 02-Jul-20 4:32 PM View: | Portola Pharmaceuticals Inc (PTLA) | 02-Jul-20 | Disposition | 15,575 | $18.00 | $280,350.00 | (100%) 15.57K to 0 | |
| 15-Jun-20 7:06 PM View: | Portola Pharmaceuticals Inc (PTLA) | 12-Jun-20 | Grant | 7,281 | -- | -- | 88% 8.29K to 15.57K | |
| 04-Aug-20 9:30 PM View: | Global Blood Therapeutics, ... (GBT) | 12-Jun-20 | Gift | 306,000 | -- | -- | (23%) 1.34M to 1.04M | |
| 08-Jun-20 4:57 PM View: | Amicus Therapeutics, Inc. (FOLD) | 04-Jun-20 | Grant | 5,855 | -- | -- | 5% 125.14K to 131.0K | |
| 29-Apr-20 4:17 PM View: | Global Blood Therapeutics, ... (GBT) | 28-Apr-20 | Market Sale (Planned) | 40,000 | $80.00 | $3,200,160.00 | (4%) 1.08M to 1.04M | 43% |
| 29-Apr-20 4:17 PM View: | Global Blood Therapeutics, ... (GBT) | 27-Apr-20 | Market Sale (Planned) | 2,817 | $80.87 | $227,814.00 | (< 1%) 1.08M to 1.08M | 44% |
| 20-Feb-20 6:20 PM View: | Global Blood Therapeutics, ... (GBT) | 18-Feb-20 | Market Sale (Planned) | 4,007 | $70.54 | $282,660.00 | (< 1%) 1.08M to 1.08M | 36% |
| 04-Feb-20 8:51 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Feb-20 | Payment of Exercise | 14,169 | $65.26 | $924,669.00 | (1%) 1.1M to 1.08M | 31% |
| 04-Feb-20 8:51 PM View: | Global Blood Therapeutics, ... (GBT) | 01-Feb-20 | Option Exercise | 33,063 | -- | -- | 3% 1.07M to 1.1M | |
| 04-Feb-20 8:51 PM View: | Global Blood Therapeutics, ... (GBT) | 31-Jan-20 | Grant | 579 | $36.68 | $21,237.70 | < 1% 1.06M to 1.07M | |
| 23-Jan-20 4:05 PM View: | Global Blood Therapeutics, ... (GBT) | 22-Jan-20 | Market Sale (Planned) | 40,000 | $81.73 | $3,269,050.00 | (4%) 1.1M to 1.06M | 45% |
| 23-Jan-20 4:05 PM View: | Global Blood Therapeutics, ... (GBT) | 21-Jan-20 | Market Sale (Planned) | 40,000 | $82.20 | $3,288,100.00 | (3%) 1.14M to 1.1M | 45% |
| 17-Dec-19 8:21 PM View: | Global Blood Therapeutics, ... (GBT) | 13-Dec-19 | Payment of Exercise | 43,383 | $76.88 | $3,335,280.00 | (4%) 1.19M to 1.14M | 41% |
| 17-Dec-19 8:21 PM View: | Global Blood Therapeutics, ... (GBT) | 13-Dec-19 | Option Exercise | 87,500 | -- | -- | 8% 1.1M to 1.19M | |
| 09-Dec-19 6:25 PM View: | Global Blood Therapeutics, ... (GBT) | 06-Dec-19 | Market Sale (Planned) | 40,000 | $77.10 | $3,083,930.00 | (4%) 1.14M to 1.1M | 41% |
| 09-Dec-19 6:25 PM View: | Global Blood Therapeutics, ... (GBT) | 05-Dec-19 | Market Sale (Planned) | 40,000 | $74.97 | $2,998,870.00 | (3%) 1.18M to 1.14M | 40% |